DURHAM, N.C., June 23, 2023 (GLOBE NEWSWIRE) — Parexel, one of the worldâs largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the appointments of Michael Bruun, Partner, Global co-Head of Private Equity, Goldman Sachs Asset Management, and John Groetelaars,…Read More
Parexel Announces Updates to Board of Directors
